Nanotechnology may improve gene therapy for blindness
Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness.
A collaborative team of researchers with Oregon Health & Science University and Oregon State University have developed an approach that uses lipid nanoparticles - tiny, lab-made balls of fat - to deliver strands of messenger ribonucleic acid, or mRNA, inside the eye.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Blindness | Covid Vaccine | COVID-19 | Gene Therapy | Genetics | Nanotechnology | Opthalmology | Pharmaceuticals | Science | Vaccines